181 related articles for article (PubMed ID: 36219586)
1. A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study.
Cuvelier GDE; Ng B; Abdossamadi S; Nemecek ER; Melton A; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; Ostroumov E; Schultz KR
Blood Adv; 2023 Jul; 7(14):3612-3623. PubMed ID: 36219586
[TBL] [Abstract][Full Text] [Related]
2. Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies.
Schultz KR; Kariminia A; Ng B; Abdossamadi S; Lauener M; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savasan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; Azadpour S; Ostroumov E; Subrt P; Halevy A; Mostafavi S; Cuvelier GDE
Blood; 2020 Apr; 135(15):1287-1298. PubMed ID: 32047896
[TBL] [Abstract][Full Text] [Related]
3. A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation.
Chirumbolo G; Dicataldo M; Barone M; Storci G; De Matteis S; Laprovitera N; Sinigaglia B; Barbato F; Maffini E; Cavo M; Bonifazi F; Arpinati M
Transplant Cell Ther; 2023 May; 29(5):302.e1-302.e8. PubMed ID: 36796518
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease.
Subburaj D; Ng B; Kariminia A; Abdossamadi S; Lauener M; Nemecek ER; Rozmus J; Kharbanda S; Kitko CL; Lewis VA; Schechter-Finklestein T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Coulter D; Chewning JH; Joyce M; Pawlowska AB; Megason GC; Lawitschka A; Ostroumov E; Klein Geltink R; Cuvelier GDE; Schultz KR
Blood; 2022 Jan; 139(2):287-299. PubMed ID: 34534280
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of the cytokine panel in the diagnosis of ocular chronic graft-versus-host disease].
Cheng XJ; Ji R; Huan RH; Huang SQ; Fan W; Zhao YC; Yuan RD; Wang XQ; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):242-248. PubMed ID: 38716595
[No Abstract] [Full Text] [Related]
6. Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria.
Cuvelier GDE; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; West LJ; Pan B; Al Hamarneh YN; Halevy A; Schultz KR
Blood; 2019 Jul; 134(3):304-316. PubMed ID: 31043425
[TBL] [Abstract][Full Text] [Related]
7. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
Front Immunol; 2019; 10():1879. PubMed ID: 31507582
[TBL] [Abstract][Full Text] [Related]
8. Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review.
Milosevic E; Babic A; Iovino L; Markovic M; Grce M; Greinix H
Front Immunol; 2022; 13():1033263. PubMed ID: 36389657
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.
Fujii H; Cuvelier G; She K; Aslanian S; Shimizu H; Kariminia A; Krailo M; Chen Z; McMaster R; Bergman A; Goldman F; Grupp SA; Wall DA; Gilman AL; Schultz KR
Blood; 2008 Mar; 111(6):3276-85. PubMed ID: 17925486
[TBL] [Abstract][Full Text] [Related]
10. Recent advances and research progress in biomarkers for chronic graft versus host disease.
Ji R; Li Y; Huang R; Xiong J; Wang X; Zhang X
Crit Rev Oncol Hematol; 2023 Jun; 186():103993. PubMed ID: 37061073
[TBL] [Abstract][Full Text] [Related]
11. Biomarker Panel for Chronic Graft-Versus-Host Disease.
Yu J; Storer BE; Kushekhar K; Abu Zaid M; Zhang Q; Gafken PR; Ogata Y; Martin PJ; Flowers ME; Hansen JA; Arora M; Cutler C; Jagasia M; Pidala J; Hamilton BK; Chen GL; Pusic I; Lee SJ; Paczesny S
J Clin Oncol; 2016 Aug; 34(22):2583-90. PubMed ID: 27217465
[TBL] [Abstract][Full Text] [Related]
12. Elevated ADA2 Enzyme Activity at the Onset of Chronic Graft-versus-Host Disease in Children.
Bowers SM; Ng B; Abdossamadi S; Kariminia A; Cabral DA; Cuvelier GDE; Schultz KR; Brown KL
Transplant Cell Ther; 2023 May; 29(5):303.e1-303.e9. PubMed ID: 36804932
[TBL] [Abstract][Full Text] [Related]
13. Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death.
Logan BR; Fu D; Howard A; Fei M; Kou J; Little MR; Adom D; Mohamed FA; Blazar BR; Gafken PR; Paczesny S
J Clin Invest; 2023 Aug; 133(15):. PubMed ID: 37526081
[TBL] [Abstract][Full Text] [Related]
14. "Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation".
Cuvelier GDE; Li A; Drissler S; Kariminia A; Abdossamadi S; Rozmus J; Chanoine JP; Ng B; Mostafavi S; Brinkman RR; Schultz KR
Front Immunol; 2020; 11():571884. PubMed ID: 33193355
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
Kariminia A; Holtan SG; Ivison S; Rozmus J; Hebert MJ; Martin PJ; Lee SJ; Wolff D; Subrt P; Abdossamadi S; Sung S; Storek J; Levings M; Aljurf M; Arora M; Cutler C; Gallagher G; Kuruvilla J; Lipton J; Nevill TJ; Newell LF; Panzarella T; Pidala J; Popradi G; Szwajcer D; Tay J; Toze CL; Walker I; Couban S; Storer BE; Schultz KR
Blood; 2016 Jun; 127(24):3082-91. PubMed ID: 27020088
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease.
Baumrin E; Baker LX; Byrne M; Martin PJ; Flowers ME; Onstad L; El Jurdi N; Chen H; Beeghly-Fadiel A; Lee SJ; Tkaczyk ER
JAMA Dermatol; 2023 Apr; 159(4):393-402. PubMed ID: 36884224
[TBL] [Abstract][Full Text] [Related]
17. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
Kuzmina Z; Krenn K; Petkov V; Körmöczi U; Weigl R; Rottal A; Kalhs P; Mitterbauer M; Ponhold L; Dekan G; Greinix HT; Pickl WF
Blood; 2013 Mar; 121(10):1886-95. PubMed ID: 23303823
[TBL] [Abstract][Full Text] [Related]
18. Anti-Thymocyte Globulin Prophylaxis Induces a Decrease in Naive Th Cells to Inhibit the Onset of Chronic Graft-versus-Host Disease: Results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 Study.
Naeije L; Kariminia A; Abdossamadi S; Azadpour S; Subrt P; Kuzeljevic B; Irvine MA; Walker I; Schultz KR
Biol Blood Marrow Transplant; 2020 Mar; 26(3):438-444. PubMed ID: 31756535
[TBL] [Abstract][Full Text] [Related]
19. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease.
Hansen JL; Juckett MB; Foster MA; Rumble ME; Morris KE; Hematti P; Costanzo ES
J Cancer Surviv; 2023 Jun; 17(3):646-656. PubMed ID: 36917433
[TBL] [Abstract][Full Text] [Related]
20. Chronic graft-versus-host disease in pediatric patients: Differences and challenges.
Haroun E; Agrawal K; Leibovitch J; Kassab J; Zoghbi M; Dutta D; Lim SH
Blood Rev; 2023 Jul; 60():101054. PubMed ID: 36805299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]